-Qing Ye Researcher Activity Profile

Research Author Detailed Information 

Qing Ye Publication Rate By Year

Qing Ye has published 1 paper(s) in 2004, 5 paper(s) in 2006, 9 paper(s) in 2007, 6 paper(s) in 2008, for a total of 21 research publications in total.

Qing Q Ye Author Information

LAST NAME: ye

FIRST NAME: qing

INITIALS: Q

AFFILIATION:

Papers

Qing Ye's Publication Record

1. [A study of the association between PPARr2 gene Pro12Ala polymorphism and NAFLD] Year Published: 2007
Department of Gastroenterology, General Hospital of Tianjin Medical University, Tianjin 300052, China. yeqing022@163.com
2. [Cephlometric analysis of the cranial base in class II(1) malocclusions with different vertical types in adolescences] Year Published: 2004
Shanghai Central Hospital of Yangpu District, Shanghai 200090, China.
3. [A high sensitivity optical multichannel analyzer] Year Published: 2006
Photonics Center, College of Physics, Nankai University, Tianjin, China.
4. [Impact of childhood abuses on the psychology and behaviors regarding harmful dietary pattern in adolescents] Year Published: 2006
School of Public Health, Anhui Medical University, Hefei 230032, China.
5. [Cephalometric comparisons of the craniofacial characteristics of Class II 1 malocclusions with different vertical types in adolescences] Year Published: 2006
Department of Stomatology, Shanghai Central Hospital of Yangpu District, Shanghai 200090, China.
6. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells] Year Published: 2006
Department of Urology, Tongii Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China.
7. [Correlation between psychopathological symptoms, coping style in adolescent and childhood repeated physical, emotional maltreatment] Year Published: 2007
Department of Maternal and Child Health, School of Public Health, Anhui Medical University, Hefei 230032, China.
8. MRI detection of macrophages labeled using micrometer-sized iron oxide particles. Year Published: 2007
Pittsburgh NMR Center for Biomedical Research, Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
9. Antigen-binding characteristics of AbCD71 and its inhibitory effect on PHA-induced lymphoproliferation. Year Published: 2007
Department of Immunology and Pharmacology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
10. Doxycycline attenuated lung injury by its biological effect apart from its antimicrobial function. Year Published: 2007
Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka, Japan. fujita@kokyu.med.kyushu-u.ac.jp
11. [Report on the study of who ear and hearing disorders survey protocol in Guizhou province] Year Published: 2007
Hearing Rehabilitation Research Center, Guizhou Provincial People's Hospital, Guiyang, China. hearing@5055.cn
12. Antidepressant-associated switches from depression to mania in severe bipolar disorder. Year Published: 2007
Department of Psychiatry and Behavioral Sciences, Stony Brook University, Stony Brook, NY, USA.
13. SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase Dependent Cancers. Year Published: 2008
Authors' Affiliations: Department of Medicine, Program in Molecular Pharmacology, and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York; and Serenex, Inc., Durham, North Carolina.
14. Antidepressant-associated switches from depression to mania in severe bipolar disorder. Year Published: 2007
Department of Psychiatry and Behavioral Sciences, Stony Brook University, Stony Brook, NY 11794-8790, USA. gabrielle.carlson@stonybrook.edu
15. Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel. Year Published: 2008
Department of Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
16. Doxycycline attenuated lung injury by its biological effect apart from its antimicrobial function. Year Published: 2007
Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka, Japan. fujita@kokyu.med.kyushu-u.ac.jp
17. SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers. Year Published: 2008
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA.
18. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells] Year Published: 2006
Department of Urology, Tongii Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China.
19. Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel. Year Published: 2008
Department of Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
20. Antisense RNA of survivin gene inhibits the proliferation of leukemia cells and sensitizes leukemia cell line to taxol-induced apoptosis. Year Published: 2008
Department of Immunology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China, liwenhan@hotmail.com.
21. SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers. Year Published: 2008
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA.